Summit Tx Capital, L.P. Incyte Corp Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q1 2025
A detailed history of Summit Tx Capital, L.P. transactions in Incyte Corp stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 22,900 shares of INCY stock, worth $1.44 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
22,900Holding current value
$1.44 Million% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding INCY
# of Institutions
695Shares Held
192MCall Options Held
567KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$1.93 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.34 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.26 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$933 Million0.55% of portfolio
-
State Street Corp Boston, MA10MShares$630 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $14B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...